Arrhythmias & electrophysiology

Conduction System Pacing in Pediatric Patients: Outcomes From a Multicenter International Cohort

JACC Clin ElectrophysiolPublished international, multicenter, retrospective study

Authors' conclusion

CSP is a feasible, safe, and durable physiological pacing strategy in children, with excellent long-term CSP preservation and stable electrical performance despite ongoing somatic growth. CSP may also provide effective physiological resynchronization in pediatric patients requiring CRT.

Study context

Population
Patients aged ≤18 years undergoing His bundle pacing or left bundle branch area pacing
Participants
120 patients
Outcome
Long-term preservation of CSP
Follow-up
Median 24 months (Q1-Q3: 10-54 months)
Methodological detailsconsecutive patients, 9 experienced centers
  • Consecutive patients
  • 9 experienced centers

Main finding

As reported in the abstract

Long-term preservation of CSP

Conduction system pacing (CSP) preserved, among 101 patients with CSP at implantation and follow-up capture assessment

95

94.1%

Kaplan-Meier-estimated freedom from loss of CSP at 1 year

100.0%

Kaplan-Meier-estimated freedom from loss of CSP at 2 and 3 years

98.2%

95% CI 94.7%–100.0%

Observational data: associations, not effects.

Further findings

Baseline indications

Congenital atrioventricular block
68 (56.7%)
Congenital heart disease
41 (34.2%)
CSP for heart failure/CRT
12 (10.0%)

Acute CSP implantation success

Successful
116 patients (96.7%)

Electrical lead performance

Remained stable

Left ventricular ejection fraction, CRT subgroup

Improved from 28.8% ± 9.4% to 46.8% ± 12.0%
P < 0.001

Safety

CSP lead-related complications
10 patients (8.3%)
Reintervention required
9 (7.5%)

Original publication

Conduction System Pacing in Pediatric Patients: Outcomes From a Multicenter International Cohort. JACC Clin Electrophysiol. Published 5 November 2026. doi:10.1016/j.jacep.2026.10.010

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.